|

US Elections: Time runs short for Trump to reverse the trend – Standard Chartered

A month before election day, Biden’s lead remains consistently solid, rising marginally in rolling average of polls whereas outside of average of polls, some of the most recent results show a record double-digit lead for Biden. Meanwhile, Electoral College projections are similar to early September: Biden leads but still many toss-up states. Trump’s recent COVID-19 diagnosis introduced further volatility into a tense campaign, as per Standard Chartered.

Key quotes

“Four weeks before election day on 3 November and Biden’s lead in the US presidential race remains strong: average national polls show him leading Trump by 8ppt, similar to early September. In terms of the Electoral College, the projections are very similar, with Biden projected to win 279 votes against Trump’s 125. So, even if Biden were to lose the 134 still-too-close-to-call electoral votes from battleground states, he would still have more than the 270 needed to win.”

“The most dramatic piece of news of the recent campaign has been Trump testing positive for COVID-19 on 1 October. The consequences for the campaign are still very unclear. The most immediate consequence is Trump’s inability to hold campaign rallies as well as fundraiser events – his campaign is notably trailing Biden’s in terms of funding. Should the president become unable to exercise his daily presidential duties, VP Mike Pence would take over, under the 25th amendment. Should the president still be physically unfit by election day on 3 November, things could get complicated.”

“Problematically, millions of Americans have already cast their votes. And so the likelihood would be that the presidential election – which is unlikely to be postponed – would go ahead with the same names on the ballot, and a decision on a Republican candidate would need to be made between 3 November – election day – and 14 December, the day the Electoral College convenes. The legalities of all these various scenarios would likely be disputed and the situation could get complicated. For now, the Trump campaign’s latest declarations foresee the president coming back to the race sooner, rather than later.” 

Author

More from FXStreet Team
Share:

Editor's Picks

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus. 

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.